Investigational New Drugs 1990-08-01

Bisantrene in advanced, hormone-resistant carcinoma of the prostate: an Illinois Cancer Council phase II study.

N J Vogelzang, V J Lanzotti, B Muntean, R R Blough

文献索引：Invest. New Drugs 8(3) , 313-5, (1990)

结构式	名称/CAS号	分子式	全部文献
	比生群 CAS:78186-34-2	C₂₂H₂₂N₈

In vitro effects of bisantrene on fresh clonogenic leukemia ...
1990-01-01
[Haematologica 75(6) , 527-31, (1990)]

Phase II trial of Bisantrene for metastatic melanoma: an Ill...
1991-01-01
[Med. Pediatr. Oncol. 19(2) , 126-8, (1991)]

Retroviral transfer of the human MDR1 gene confers resistanc...
2014-04-29
[Clin. Cancer Res. 2(6) , 973-80, (1996)]

Synthesis, DNA-damaging and cytotoxic properties of novel to...
1998-01-20
[Bioorg. Med. Chem. Lett. 8(2) , 121-6, (1998)]

Bisantrene in relapsed and refractory acute myelogenous leuk...
1993-02-01
[Leuk. Lymphoma 9(3) , 217-20, (1993)]